Please turn JavaScript on
Drug Development and Delivery icon

Drug Development and Delivery

Want to stay in touch with the latest updates from Drug Development and Delivery? That's easy! Just subscribe clicking the Follow button below, choose topics or keywords for filtering if you want to, and we send the news to your inbox, to your phone via push notifications or we put them on your personal page here on follow.it.

Reading your RSS feed has never been easier!

Website title: Drug Development & Delivery - The Latest Methods in Drug Development

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  2.77 / day

Message History

SELLAS Life Sciences Group has reported positive results from its pivotal Phase 3 REGAL trial, with its investigational cancer vaccine galinpepimut-S (GPS) demonstrating a statistically significant overall survival benefit in patients with acute myeloid leukemia (AML).

The randomized study met its primary endpoint, showing a 41% reduction in the risk of death among pat...


Read full story

Enterprise Therapeutics has received orphan medicinal product designation from the European Medicines Agency (EMA) for ETD001, its investigational inhaled therapy being developed for people with cystic fibrosis (CF). The designation, granted following a positive opinion from the EMA’s Committee for Orphan Medicinal Products (COMP), recognizes the potential of ETD001 to addres...


Read full story

A collaboration between Nuclera and researchers at the University of Cambridge has demonstrated a cell-free protein production method that could shorten the time required to obtain high-resolution structural data on difficult-to-produce drug targets. The study, published as a preprint on bioRxiv, describes a workflow that combines cell-free protein synthesis, proprietary lipi...


Read full story

CPHI Milan recorded its largest attendance to date, bringing together more than 63,000 pharmaceutical industry professionals from 168 countries for three days of business development, technical discussions and networking.

Held October 6-8 at Fiera Milano, the 2026 event saw attendance increase by more than 6% compared with the previous Milan edition in 2024. More than ...


Read full story

The U.S. Food and Drug Administration (FDA) is changing how it refers to artificial intelligence (AI), adopting the term “Super Intelligence” (SI) in new public-facing communications beginning November 16, 2026. The terminology change follows a September 29 executive order issued by President Donald Trump, directing federal agencies to replace references to artificial intelli...


Read full story